Literature DB >> 1834951

Amiloride analogues induce responses in isolated rat cardiovascular tissues by inhibition of Na+/Ca2+ exchange.

L Brown1, E J Cragoe, K C Abel, S W Manley, J R Bourke.   

Abstract

The role of inhibition of Na+/Ca2+ exchange in the positive inotropic, negative chronotropic and vasorelaxant responses to amiloride and some of its analogues was investigated in isolated cardiovascular tissues from female Wistar rats. The compounds tested were amiloride, 5-(N-ethyl-N-isopropyl)amiloride (EIPA, a potent inhibitor of Na+/H+ exchange), phenamil and 2',4'-dimethylbenzamil (DMB), both potent Na+ channel inhibitors with activity against Na+/Ca2+ exchange, and 5-(N-4-chlorobenzyl)-2',4'-dimethylbenzamil (CBDMB), a potent inhibitor of Na+/Ca2+ exchange with reduced activity against Na+ channels compared with its parent compound DMB. Phenamil, DMB and CBDMB increased the force of contraction of right ventricular papillary muscles with similar potencies (-log EC50 values: 4.77 +/- 0.06, 5.09 +/- 0.09, 4.97 +/- 0.17 respectively), while amiloride and EIPA gave small negative inotropic responses. All compounds gave negative chronotropic responses at similar concentrations to those which exerted inotropic effects. Inhibition of KCl contraction of endothelium-free aortic rings was observed with all compounds tested. Phenamil, DMB and CBDMB but not amiloride or EIPA showed a shift to the left of the concentration-response curves in the presence of intact endothelium. These results provide further evidence for positive inotropic and endothelium-dependent vasorelaxant effects of amiloride analogues mediated by inhibition of Na+/Ca2+ exchange.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834951     DOI: 10.1007/bf00167222

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Amiloride selectively blocks the low threshold (T) calcium channel.

Authors:  C M Tang; F Presser; M Morad
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

Review 2.  Modulation of sodium/calcium exchange: a hypothetical positive inotropic mechanism.

Authors:  U Ravens; E Wettwer
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

Review 3.  Sodium/calcium exchange and the control of contractility in cardiac muscle and vascular smooth muscle.

Authors:  M P Blaustein
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

Review 4.  The role of endothelium in the responses of vascular smooth muscle to drugs.

Authors:  R F Furchgott
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

Review 5.  Current therapeutic principles in the acute management of severe congestive heart failure.

Authors:  P A Poole-Wilson
Journal:  Am J Cardiol       Date:  1988-08-11       Impact factor: 2.778

6.  Pyrazine diuretics. II. N-amidino-3-amino-5-substituted 6-halopyrazinecarboxamides.

Authors:  E J Cragoe; O W Woltersdorf; J B Bicking; S F Kwong; J H Jones
Journal:  J Med Chem       Date:  1967-01       Impact factor: 7.446

7.  An electrophysiological study of amiloride on sino-atrial node cells and ventricular muscle of rabbit and dog.

Authors:  H Satoh; K Hashimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

8.  Amiloride analogues cause endothelium-dependent relaxation in the canine coronary artery in vitro: possible role of Na+/Ca2+ exchange.

Authors:  T M Cocks; P J Little; J A Angus; E J Cragoe
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 9.  Amiloride and its analogs as tools in the study of ion transport.

Authors:  T R Kleyman; E J Cragoe
Journal:  J Membr Biol       Date:  1988-10       Impact factor: 1.843

10.  Na-H exchange is a major pathway for Na influx in rat vascular smooth muscle.

Authors:  P J Little; E J Cragoe; A Bobik
Journal:  Am J Physiol       Date:  1986-11
View more
  6 in total

1.  Reversal of cardiac dysfunction by selective ET-A receptor antagonism.

Authors:  Anthony Allan; Andrew Fenning; Scott Levick; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.

Authors:  Vincent Chan; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.

Authors:  G Miric; C Dallemagne; Z Endre; S Margolin; S M Taylor; L Brown
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

4.  Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.

Authors:  Stevo Mirkovic; Anne-Marie L Seymour; Andrew Fenning; Anna Strachan; Solomon B Margolin; Stephen M Taylor; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Na+ overload during ischemia and reperfusion in rat hearts: comparison of the Na+/H+ exchange blockers EIPA, cariporide and eniporide.

Authors:  Michiel ten Hove; Jan G van Emous; Cees J A van Echteld
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

6.  Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats.

Authors:  Abishek Iyer; Lindsay Brown
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-04       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.